Q4 2023 BioNTech SE Earnings Call Transcript
Welcome to the BioNTech's Fourth Quarter and Full Year 2023 Earnings Call.
I would like to hand the call over to Dr. Victoria Meissner, Vice President of Strategy and Investor Relations. Please go ahead.
Thank you. Good morning and good afternoon. Thank you for joining BioNTech's fourth quarter and full year 2023 earnings Call. As a reminder, the slides we'll be using during this call and the corresponding press release we issued this morning can be found in the Investor Relations section of our website.
On the next slide, you will see our forward-looking statements disclaimer. Additional information about these statements and other risks are described in our filings with the U.S. Securities and Exchange Commission. Forward-looking statements in this call are subject to significant risks and uncertainties, speak only as of the date of this conference call, and we undertake no obligation to update or revise any of these statements. On Slide 3, you can find the agenda for today's call.
Today, I'm joined by the following
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |